MARC Record from marc_nuls

LEADER: 05366cam 22003974a 4500
001 9919988530001661
005 20150423123831.0
008 010411s2001 enka b 001 0 eng
010 $a 2001031534
015 $aGBA1-W8020
019 $a47271414
020 $a1840645954
029 1 $aUKM$bbA1W8020
035 $a(CSdNU)u103927-01national_inst
035 $a(OCoLC)46732568
035 $a(Sirsi) 01-AAM-9251
040 $aDLC$cDLC$dUKM$dC#P$dTVJ$dOrPss
042 $apcc
049 $aCNUM
050 00 $aHD9999.B442$bE25 2001
245 04 $aThe economics of biotechnology /$cJames D. Gaisford ... [et al.].
260 $aCheltenham, UK ;$aNorthampton, MA :$bEdward Elgar,$cc2001.
300 $axv, 246 p. :$bill. ;$c25 cm.
504 $aIncludes bibliographical references (p. 231-241) and index.
505 0 $aBiotechnology -- The potential benefits of biotechnology -- Gains from technological change -- Producer benefits -- Consumer benefits -- Externality benefits -- Developing country benefits -- Realising potential benefits -- Biotechnological risks -- Risks to human health -- Risks to the environment -- Producer to producer externalities -- What are the issues? -- Who are the vested interests? -- Intellectual property -- The changing nature of biological research -- The economics of protecting intellectual property -- The environment -- Release and adoption under uncertainty -- Potential environmental externalities -- Modelling decision-making under uncertainty -- Diverging policy approaches -- Biotechnology as a negative public good -- Aggregate GMO output as a negative public good -- A framework for assessing environmental externalities -- Assessing the impact of GMOs with external environmental costs -- Biotechnology as a negative or positive public good -- A GMO with external environmental benefits -- The GM product has smaller external environmental costs than the non-GM -- GMO inputs are overpriced due to imperfect competition -- International regulation in the Biosafety Protocol -- Consumer issues -- Why do consumers care? -- Evidence of consumer concerns -- What are the consumer concerns? -- The origins of consumer concerns -- Regulatory responses -- Imperfect information -- Hidden quality and long-term food safety -- Consumers -- Non-GM farms: a competitive fringe -- The single biotechnology firm -- A single market with hidden quality - when market segmentation is not possible -- Standard monopoly pricing -- Pre-emptive and accommodating pricing -- Biotechnology, agriculture and the 'Lemons Problem' -- A general model without market segmentation -- The farm sector -- The biotechnology industry -- The hidden quality problem revisited -- Solutions to hidden quality - labelling options -- Overview of identity preservation systems -- Perfect identity preservation -- Costly identity preservation -- Cheating and its control -- Non-compliance in a mandatory GM food IPS -- Misrepresentation in a voluntary non-GM food IPS -- Consumer conundrums and policy -- Ethical concerns -- Ethical objections to biotechnology -- Biotechnology and ethics -- Religious attitudes towards genetic modification and biotechnology -- Specific religious objections -- Issues of safety -- Ownership and competitive issues -- Human ethics -- Ethical decision-making and the ethical matrix -- An approach to formally modelling ethical concerns -- Ethical dimensions of food safety and environmental concerns -- Ethics and hidden quality -- Ethics and externalities -- Who gets the biotechnology rents? -- Capturing the rents -- Biotechnology and the changing structure of industry -- Structural trends: merger, acquisition and alliance activity -- The changing structure of the input supply sector -- Insights from economic theory -- Changes in downstream feed and food processing industries -- The future structure of the biotechnology industry -- International issues -- Biotechnology and international trade -- Hidden quality: a GM import embargo versus unlabelled imports -- Revealed quality: labelling of GM imports versus an embargo -- External costs: GM imports as negative public goods -- The World Trade Organisation and trade in genetically modified products -- International protection of intellectual property -- Biotechnology and the international distribution of income -- Classification of technical progress -- Neutral technical progress, the terms of trade and income distribution -- The effect of capital-saving technical progress -- The effect of labour-saving technical progress -- The effect of growth on income distribution -- Alternative or additional views on income distribution -- Economics and the future of biotechnology -- The nature of biotechnological change -- Pushing the limits of economic analysis -- Public policy role -- Developing country issues -- Crystal ball gazing ....
650 0 $aBiotechnology industries.
650 0 $aBiotechnology$xIndustrial applications.
650 0 $aBiotechnology$xResearch.
650 2 $aBiotechnology$xeconomics.
650 2 $aBiotechnology$xtrends.
700 1 $aGaisford, James D.
948 $a04/30/2002$b06/13/2002
982 $aHD9999.B442$aE25$a2001
983 $a31786101617006
994 $a92$bCNU
999 $aHD9999.B442 E25 2001$wLC$c1$i31786101617006$d11/12/2004$e11/6/2004 $f3/18/2004$g1$lCIRCSTACKS$mNULS$n1$rY$sY$tBOOK$u6/13/2002